» Articles » PMID: 24574081

Hyperphagia: Current Concepts and Future Directions Proceedings of the 2nd International Conference on Hyperphagia

Abstract

Objective: Hyperphagia is a central feature of inherited disorders (e.g., Prader-Willi Syndrome) in which obesity is a primary phenotypic component. Hyperphagia may also contribute to obesity as observed in the general population, thus raising the potential importance of common underlying mechanisms and treatments. Substantial gaps in understanding the molecular basis of inherited hyperphagia syndromes are present as are a lack of mechanistic of mechanistic targets that can serve as a basis for pharmacologic and behavioral treatments.

Design And Methods: International conference with 28 experts, including scientists and caregivers, providing presentations, panel discussions, and debates.

Results: The reviewed collective research and clinical experience provides a critical body of new and novel information on hyperphagia at levels ranging from molecular to population. Gaps in understanding and tools needed for additional research were identified.

Conclusions: This report documents the full scope of important topics reviewed at a comprehensive international meeting devoted to the topic of hyperphagia and identifies key areas for future funding and research.

Citing Articles

Defining Hyperphagia for Improved Diagnosis and Management of MC4R Pathway-Associated Disease: A Roundtable Summary.

Heymsfield S, Clement K, Dubern B, Goldstone A, Haqq A, Kuhnen P Curr Obes Rep. 2025; 14(1):13.

PMID: 39856371 PMC: 11762201. DOI: 10.1007/s13679-024-00601-z.


Eating behavior patterns, metabolic parameters and circulating oxytocin levels in patients with obesity: an exploratory study.

Elena C, Flavia L, Davide M, Mariaignazia C, Chandra M, Orietta G Eat Weight Disord. 2025; 30(1):6.

PMID: 39820758 PMC: 11742293. DOI: 10.1007/s40519-024-01698-w.


Exploring the therapeutic potential of precision medicine in rare genetic obesity disorders: a scientific perspective.

Collet T, Schwitzgebel V Front Nutr. 2025; 11():1509994.

PMID: 39777073 PMC: 11705004. DOI: 10.3389/fnut.2024.1509994.


The expanding landscape of genetic causes of obesity.

Semenova E, Guo A, Liang H, Hernandez C, John E, Thaker V Pediatr Res. 2024; .

PMID: 39690244 DOI: 10.1038/s41390-024-03780-6.


Caregiver-reported increased food motivation and adiposity in dogs receiving antiseizure drugs.

Morros-Nuevo A, Packer R, Regan N, Raffan E Vet Rec. 2024; 195(12):e4907.

PMID: 39658808 PMC: 11639269. DOI: 10.1002/vetr.4907.


References
1.
Rada P, Avena N, Hoebel B . Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell. Neuroscience. 2005; 134(3):737-44. DOI: 10.1016/j.neuroscience.2005.04.043. View

2.
De Peppo F, Di Giorgio G, Germani M, Ceriati E, Marchetti P, Galli C . BioEnterics intragastric balloon for treatment of morbid obesity in Prader-Willi syndrome: specific risks and benefits. Obes Surg. 2008; 18(11):1443-9. DOI: 10.1007/s11695-008-9509-8. View

3.
Kublaoui B, Lloyd Holder Jr J, Gemelli T, Zinn A . Sim1 haploinsufficiency impairs melanocortin-mediated anorexia and activation of paraventricular nucleus neurons. Mol Endocrinol. 2006; 20(10):2483-92. DOI: 10.1210/me.2005-0483. View

4.
Davis R, Swiderski R, Rahmouni K, Nishimura D, Mullins R, Agassandian K . A knockin mouse model of the Bardet-Biedl syndrome 1 M390R mutation has cilia defects, ventriculomegaly, retinopathy, and obesity. Proc Natl Acad Sci U S A. 2007; 104(49):19422-7. PMC: 2148305. DOI: 10.1073/pnas.0708571104. View

5.
Stunkard A, Messick S . The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res. 1985; 29(1):71-83. DOI: 10.1016/0022-3999(85)90010-8. View